Rare Genetic Syndrome Linked to 121-Fold Higher Risk of Allergic Esophagitis
A pediatric case series reveals that children with a rare developmental disorder face a drastically increased likelihood of severe allergic inflammation in the food pipe.
Children diagnosed with a rare developmental disorder called Rubinstein-Taybi syndrome face an unexpectedly high risk of developing a severe allergic condition that inflames the food pipe, according to a pediatric case series. Researchers discovered that patients with the genetic condition had a prevalence of eosinophilic esophagitis, a chronic immune disorder causing painful swallowing and vomiting, that was roughly 121 times greater than that of the general population.
Rubinstein-Taybi syndrome is a rare multisystem condition characterized by intellectual disability, distinctive facial features, poor growth, and frequent digestive complications. While medical teams have long recognized that affected individuals struggle with feeding difficulties and swallowing problems, the true frequency of allergic digestive diseases in this population remained poorly understood. To investigate this connection, a clinical team at Phoenix Children’s Hospital examined medical records spanning a decade from 2012 to 2022.
How Genetic Variations Shape Digestive Health Risks
The retrospective review, published in JPGN Reports, identified 27 pediatric patients diagnosed with Rubinstein-Taybi syndrome. Among these individuals, 15 carried identifiable genetic variants linked to the condition. Specifically, 12 patients had alterations in the CREBBP gene, which codes for a regulatory protein known as CREB-binding protein, while 3 patients had variants in the EP300 gene. Both genes produce vital enzymes that help control how other genes are turned on and off inside cells throughout the body.
More than half of the cohort, or 63 percent, reported persistent gastrointestinal symptoms such as vomiting, food getting stuck, or reliance on feeding tubes. Out of that group, eight patients underwent an upper endoscopy procedure, which involves inserting a flexible camera down the throat to inspect the digestive lining and take tiny tissue samples for microscopic analysis.
Striking Prevalence Rates and Diagnostic Challenges
Microscopic examination of the tissue samples revealed that four of the patients undergoing endoscopy had eosinophilic esophagitis, an allergic disease marked by a massive buildup of white blood cells called eosinophils in the esophagus. This translated to 15 percent of the entire syndrome cohort receiving a diagnosis of the allergic condition. One of these four children also suffered from multi-segment eosinophilic disease extending into the stomach and duodenum, which is the upper part of the small intestine.
When comparing these numbers to the general public, where eosinophilic esophagitis affects roughly 1 in 700 individuals or 0.14 percent of the population, the researchers calculated an odds ratio of 121.6. The findings indicate that children with the syndrome face a heavily magnified statistical risk. Furthermore, among patients with the specific subtype known as RTS type 1, which involves the CREBBP gene, 60 percent of those who underwent an endoscopy were diagnosed with the allergic condition.
Understanding the Biological Link Between Genes and Immunity
The authors suggest that the genetic mutations responsible for the developmental syndrome may directly prime the immune system for allergic inflammation. The CREBBP gene helps regulate how specific white blood cells differentiate into subsets that drive allergic reactions, while also interacting with signaling proteins like STAT6 that control the production of chemical attractants for eosinophils. When these regulatory proteins are impaired by genetic variations, they may trigger runaway immune signaling in the digestive tract.
Treatments for the diagnosed children varied widely, utilizing high-dose acid-blocking medications called proton-pump inhibitors, swallowed steroid liquids, and strict elimination diets that removed common allergens like dairy, wheat, eggs, tree nuts, and shellfish. Responses to these therapies ranged from complete symptom resolution to partial improvement or no significant change, highlighting the clinical complexity of managing these overlapping conditions.
Limitations and Future Screening Recommendations
The study authors noted several limitations in their work, including its small sample size, retrospective design, and derivation from a single tertiary care center. Not every patient with digestive symptoms underwent an endoscopy, meaning the true prevalence of the allergic disorder might be even higher than reported. Because the study relied on clinical associations rather than direct laboratory experiments, the precise molecular mechanisms remain to be confirmed by future investigations.
Despite these caveats, the clinical message for caregivers and physicians is clear. The team emphasizes that pediatricians should maintain a high level of suspicion for eosinophilic esophagitis when treating children with Rubinstein-Taybi syndrome who experience chronic feeding issues or vomiting. Early endoscopic evaluation can secure a timely diagnosis, protect patients from long-term esophageal damage, and improve overall quality of life.
The research was published in JPGN reports on November 17, 2026.
This article has been fact checked for accuracy, with information verified against reputable sources. Learn more about us and our editorial process.
Last reviewed on .
Article history
- Latest version
Reference(s)
- Husain, Anita M.., et al. “Eosinophilic esophagitis and Rubinstein‐Taybi syndrome: A case series.” JPGN Reports, November 17, 2026 Wiley, doi: 10.1002/jpr3.70305. <https://doi.org/10.1002/jpr3.70305>.
Cite this page:
- Posted by Faisal Qureshi